E
Ellen W. Levy
Researcher at National Institutes of Health
Publications - 16
Citations - 987
Ellen W. Levy is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Breast cancer & Prospective cohort study. The author has an hindex of 10, co-authored 16 publications receiving 868 citations.
Papers
More filters
Journal ArticleDOI
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Marinos C. Dalakas,Goran Rakocevic,Jens Schmidt,Mohammad Salajegheh,Beverly McElroy,Michael O. Harris-Love,Joseph A. Shrader,Ellen W. Levy,James M. Dambrosia,Robert L. Kampen,David A. Bruno,Allan D. Kirk +11 more
TL;DR: It is concluded that in sIBM one series of Alemtuzumab infusions can slow down disease progression up to 6 months, improve the strength of some patients, and reduce endomysial inflammation and stressor molecules.
Journal ArticleDOI
Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.
Nicole L. Stout,Lucinda Pfalzer,Barbara A. Springer,Ellen W. Levy,Charles L. McGarvey,Jerome Danoff,Lynn H. Gerber,Peter W. Soballe +7 more
TL;DR: The prospective surveillance model is emerging as the standard of care in breast cancer treatment and is a potential cost-saving mechanism for BCRL treatment, and a shift in the paradigm of physical therapy toward a prospective Surveillance model is warranted.
Journal ArticleDOI
Clinical features of spinal and bulbar muscular atrophy.
Lindsay E. Rhodes,Brandi K. Freeman,Sungyoung Auh,Angela Kokkinis,Alison La Pean,Cheunju Chen,Tanya J. Lehky,Joseph A. Shrader,Ellen W. Levy,Michael O. Harris-Love,Nicholas A. Di Prospero,Kenneth H. Fischbeck +11 more
TL;DR: The direct correlation of testosterone levels with muscle strength indicates that androgens may have a positive effect on muscle function in spinal and bulbar muscular atrophy patients, in addition to the toxic effects described in animal models.
Journal ArticleDOI
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.
Lindsay Fernández-Rhodes,Angela Kokkinis,Michelle J. White,Charlotte A. Watts,Sungyoung Auh,Neal Jeffries,Joseph A. Shrader,Tanya J. Lehky,Li Li,Jennifer Ryder,Ellen W. Levy,Beth Solomon,Michael O. Harris-Love,Alison La Pean,Alice B. Schindler,Cheun Ju Chen,Nicholas A. Di Prospero,Kenneth H. Fischbeck +17 more
TL;DR: In this article, the 5α-reductase inhibitor dutasteride (0.5 mg per day) was administered to 50 men with genetically confirmed bulbar muscular atrophy (SBMA) for 24 months.
Journal ArticleDOI
Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer
Barbara A. Springer,Ellen W. Levy,Charles L. McGarvey,Lucinda Pfalzer,Nicole L. Stout,Lynn H. Gerber,Peter W. Soballe,Jerome Danoff +7 more
TL;DR: Most women in this cohort undergoing surgery for BC who receive PT intervention may expect a return to baseline ROM and strength by 3 months, but those who do not reach baseline, often continue to improve and reach their pre-operative levels by 1-year post-surgery.